Status:
COMPLETED
Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients
Lead Sponsor:
Singapore General Hospital
Collaborating Sponsors:
Mologic Ltd
Conditions:
Peritonitis
Eligibility:
All Genders
21-99 years
Phase:
NA
Brief Summary
Peritoneal dialysis (PD) is a home-based dialysis therapy and peritonitis is a serious complication in PD. A reliable point-of-care test to detect peritonitis is important for patients to self-detect ...
Detailed Description
A reliable point-of-care test to detect peritonitis is indeed needed for early diagnosis of peritonitis at home and seeking medical help early. We hypothesize that Periplex® is not inferior to routin...
Eligibility Criteria
Inclusion
- Adult PD patients who are followed up in Singapore General Hospital and presented with signs and symptoms suspected of peritonitis including fever, abdominal pain or cloudy effluent will be recruited for the study.
Exclusion
- 1\. PD patients who are not followed up in SGH 2. Patients with mentally challenging conditions and who are unable to provide a valid consent 3. Non-PD patients 4. PD patients who do not have signs or symptoms suspected of peritonitis
Key Trial Info
Start Date :
September 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04070196
Start Date
September 25 2019
End Date
February 24 2024
Last Update
May 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, 169856